# MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)

> **NCT00703690** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 436 (actual)

## Conditions studied

- Metabolic X Syndrome Dyslipidemia

## Interventions

- **DRUG:** MK0767
- **DRUG:** Comparator: fenofibrate
- **DRUG:** Comparator: Placebo (unspecified)

## Key facts

- **NCT ID:** NCT00703690
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-01
- **Primary completion:** 2003-12
- **Final completion:** 2003-12
- **Target enrollment:** 436 (ACTUAL)
- **Last updated:** 2015-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703690, "MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00703690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*